Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

ZVRA — Zevra Therapeutics, Inc.

UNDERVALUED (MOS +31.1%) · Quality 91/100

Value Score 30 days ago: 42.9 → today 46.2

ZVRA - Zevra Therapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 11.85 USD
Intrinsic value: 17.21 USD
Margin of safety: +31.1%
Implied growth (reverse DCF): +3.5% (model assumes +10.0%)
Valuation: UNDERVALUED
Value Score: 46.2
Quality: 91/100
Moat score: 20 (erosion: none)
UNDERVALUED (MOS +31.1%) - Quality 91/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ZVRA
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

11.85

Intrinsic value

17.21

Margin of safety

+31.1%

Implied growth (reverse DCF)

+3.5%

model assumes +10.0%

Value Score

46.2

Quality

Psychology

-13.5

Discovery

14.2

price/volume attention only

Moat score

erosion: none

Value Score: top 9% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for ZVRA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ZVRA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ZVRA undervalued?

As of 2026-11-11, ZVRA trades at 11.85 against a computed intrinsic value of 17.21 (+31.1% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Zevra Therapeutics, Inc.'s Value Score?

Zevra Therapeutics, Inc.'s Value Score is 46.2 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.